CRNXCrinetics Pharmaceuticals Inc
84.69USD0.00%Mkt Cap: 8.99B $P/E: —3d ago
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The c…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap8.99B $
Enterprise Value7.82B $
Revenue (TTM)42.16M $
Gross Profit6.62M $
Net Income (TTM)-465.32M $
Revenue/Share0.4230 USD
Last Price84.69 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees594
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS22663K1079
Valuation
P/E (Trailing)—
P/E (Forward)-21.15
PEG—
EV/EBITDA-14.36
EV/Revenue185.60
P/S213.14
P/B7.52
EPS (TTM)-5.05
EPS (Forward)-4.00
52W Range
28.73100% of range84.78
52W High84.78 USD
52W Low28.73 USD
Profitability
Gross Margin86.02%
Oper. Margin-527.35%
EBITDA Margin0.00%
Profit Margin-6046.22%
ROE-46.90%
ROA-41.32%
Growth
Revenue Growth2336.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-377.92M $
CapEx (TTM)5.76M $
FCF Margin-590.10%
FCF Yield-2.77%
Net Debt-1.16B $
Net Debt/EBITDA2.13
Balance Sheet
Debt/Equity0.05
Current Ratio15.57
Quick Ratio15.24
Book Value/Sh11.27 USD
Cash/Share11.37 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.9 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)85.50 USD
Upside (mean)+1.0%
Target Range85.00 USD – 90.00 USD
$85.00+1.0% to mean$90.00
# Analysts10
Ownership
Shares Out.106.10M
Float95.50M
Insiders1.57%
Institutions120.27%
Short Interest
Short Ratio0.8d
Short % Float6.47%
Short % Out.5.53%
Shares Short5.87M
Short (prev mo.)13.85M
Technical
SMA 5067.84 (+24.8%)
SMA 20048.95 (+73.0%)
Beta0.09
S&P 52W Chg18.16%
Avg Vol (30d)3.16M
Avg Vol (10d)2.86M
Technical Indicators
RSI (14)90.0
MACD4.2960
MACD Signal5.6557
MACD Hist.-1.3597
BB Upper84.90 USD
BB Middle84.10 USD
BB Lower83.29 USD
BB Width1.91%
ATR (14)0.7097 USD
Vol Ratio (20d)0.85x